What are the Latest Developments in Aurora Kinase Inhibitors?
Recent advancements in the field include the development of more selective inhibitors and combination therapies. Combining Aurora kinase inhibitors with other chemotherapeutic agents or targeted therapies can enhance their effectiveness and overcome resistance. Additionally, new inhibitors are being designed to target specific mutations in Aurora kinases, providing personalized treatment options for patients.